intervention,"Active, not recruiting",Completed,Enrolling by invitation,Recruiting,Terminated,Total
NA,36,71,19,315,0,441
placebo,28,16,13,261,5,323
hydroxychloroquine,20,17,7,66,9,119
standard care,8,17,8,82,2,117
convalescent plasma,8,14,4,71,0,97
questionnaire,7,19,4,61,0,91
blood sample,1,2,0,37,0,40
azithromycin,7,3,2,25,2,39
no intervention,5,3,1,26,0,35
tocilizumab,4,5,0,22,2,33
mesenchymal stem cells,4,3,3,20,0,30
ritonavir,1,6,2,18,1,28
saline,1,0,3,24,0,28
ivermectin,4,5,1,17,0,27
serology test,2,1,3,21,0,27
lopinavir,1,4,2,18,1,26
pcr,0,6,3,17,0,26
favipiravir,4,3,1,16,0,24
lopinavir/ritonavir,1,4,2,15,1,23
prone positioning,2,2,2,14,0,20
remdesivir,1,5,0,13,1,20
chloroquine,0,2,1,15,1,19
methylprednisolone,3,5,0,9,0,17
oxygen,2,0,0,15,0,17
enoxaparin,0,0,0,16,0,16
heparin,2,0,1,13,0,16
colchicine,0,0,0,14,0,14
control,1,2,0,11,0,14
exercise,1,2,1,10,0,14
plasma,0,3,1,10,0,14
saliva,1,1,1,11,0,14
survey,2,5,0,7,0,14
biological samples,1,0,1,11,0,13
interferon,0,4,1,8,0,13
online survey,1,2,2,8,0,13
vitamin c,4,1,1,7,0,13
dexamethasone,0,2,0,9,1,12
hydroxychloroquine / azithromycin,1,5,2,3,1,12
nitazoxanide,1,1,0,10,0,12
observational,2,0,0,9,0,11
vitamin d,2,0,1,8,0,11
anakinra,1,0,0,9,0,10
telehealth,0,2,1,7,0,10
bcg,2,0,0,7,0,9
igm/igg rapid test,0,2,2,5,0,9
baricitinib,1,1,0,6,0,8
nitric oxide,2,0,0,6,0,8
ruxolitinib,1,0,0,7,0,8
zinc,0,1,1,6,0,8
ace inhibitor,1,2,1,3,0,7
covid-19,1,1,0,5,0,7
ct-scan,1,1,0,5,0,7
losartan,0,1,0,6,0,7
lung ultrasound,0,0,1,6,0,7
povidone/iodine,0,2,0,5,0,7
radiotherapy,1,0,0,6,0,7
rapid test,2,2,1,2,0,7
best available therapy,0,0,0,6,0,6
blood test,1,0,0,5,0,6
data collection,0,1,0,5,0,6
exposure,1,2,0,3,0,6
igg,1,1,1,3,0,6
igg antibody test,1,2,2,1,0,6
observation,0,1,0,5,0,6
oseltamivir,1,0,0,5,0,6
sarilumab,1,2,0,3,0,6
serum test,0,1,0,5,0,6
arb,1,0,0,4,0,5
chloroquine/hydroxychloroquine,0,0,1,4,0,5
cholecalciferol,0,0,0,5,0,5
clazakizumab,1,0,0,4,0,5
doxycycline,0,2,1,2,0,5
inactivated sars-cov-2 vaccine,1,0,1,3,0,5
interleukin,0,0,0,5,0,5
interview,1,1,0,3,0,5
ly3819253,0,1,0,4,0,5
nasopharyngeal swab,0,0,0,5,0,5
rivaroxaban,0,0,0,5,0,5
sofosbuvir,0,1,0,4,0,5
telmisartan,0,0,0,5,0,5
therapeutic plasma exchange (tpe),1,2,1,1,0,5
ultrasound,0,1,0,4,0,5
anticoagulation,0,0,0,4,0,4
arbidol,1,1,0,2,0,4
biospeciman collection,0,0,0,4,0,4
biospecimen collection,0,0,0,4,0,4
bromhexine hydrochloride,1,1,1,1,0,4
budesonide,0,0,0,4,0,4
camostat mesilate,0,0,0,4,0,4
igm,0,0,1,3,0,4
igm antibodytest,0,2,0,2,0,4
immunoglobulin,0,1,0,3,0,4
low,1,0,0,3,0,4
mavrilimumab,0,0,0,4,0,4
na-831,0,0,2,2,0,4
nk cells,0,0,0,4,0,4
peginterferon,1,0,1,2,0,4
quality-of-life assessment,0,0,0,4,0,4
regn10933,0,0,0,4,0,4
regn10987,0,0,0,4,0,4
supportive care,1,1,0,2,0,4
,1,1,1,0,0,3
ad26.cov2.s,0,0,0,3,0,3
adenovirus type 5 vector,2,0,0,1,0,3
antibody test,0,0,0,3,0,3
aspirin,0,0,1,2,0,3
behavior,1,0,0,2,0,3
best supportive care,0,1,0,2,0,3
biological,0,0,0,3,0,3
blood,0,0,0,3,0,3
blood donation sms,0,1,2,0,0,3
bnt162b1,0,0,0,3,0,3
chadox1,1,0,0,2,0,3
ciclesonide,0,0,0,3,0,3
clinical data,2,0,0,1,0,3
clopidogrel,0,1,0,2,0,3
corticosteroid,0,0,0,3,0,3
coviage,0,3,0,0,0,3
covid-19 pandemic,1,1,0,1,0,3
cytosorb,0,0,0,3,0,3
daclatasvir,0,0,0,3,0,3
data record,0,0,0,3,0,3
ecg,0,0,0,3,0,3
echocardiography,0,1,0,2,0,3
famotidine,0,1,0,2,0,3
gam-covid-vac,0,1,0,2,0,3
imatinib,0,0,0,3,0,3
information,0,0,2,1,0,3
lenzilumab,1,0,0,2,0,3
mask,0,2,0,1,0,3
melatonin,1,0,0,2,0,3
mindfulness,0,0,0,3,0,3
mrna-1273,2,0,0,1,0,3
nasal,0,0,0,3,0,3
nigella sativa,0,0,0,3,0,3
non-interventional,0,0,0,3,0,3
opaganib,0,1,0,2,0,3
other,0,1,0,2,0,3
pcr/serology,0,0,0,3,0,3
prednisone,0,1,0,2,0,3
probiotic,0,0,0,3,0,3
pulmozyme,0,0,0,3,0,3
ribavirin,0,1,0,2,0,3
sample collection,0,0,0,3,0,3
sampling,0,0,0,3,0,3
sargramostim,0,0,0,3,0,3
sevoflurane,0,0,0,3,0,3
sirolimus,0,0,0,3,0,3
soc,0,0,0,3,0,3
sodium,0,0,0,3,0,3
taste,0,0,0,3,0,3
thromboprophylaxis,0,1,0,2,0,3
vitamin super b-complex,0,0,0,3,0,3
vpm1002,1,0,0,2,0,3
yoga,0,0,0,3,0,3
28-day schedule,0,0,1,1,0,2
acalabrutinib,1,0,0,1,0,2
acetylsalicylic acid,0,1,0,1,0,2
adjuvant,0,0,0,2,0,2
aeonose,0,2,0,0,0,2
antibiotics,0,1,0,1,0,2
antihypertensives,1,0,0,1,0,2
assessment of work-related stress,0,1,0,1,0,2
atorvastatin,0,0,0,2,0,2
ayurveda,0,2,0,0,0,2
bacille calmette-guã©rin (bcg),0,0,0,2,0,2
behavioral,0,0,1,1,0,2
bevacizumab,0,1,0,1,0,2
biological data,2,0,0,0,0,2
bnt162b2,0,0,0,2,0,2
breath test,0,0,0,2,0,2
canakinumab,1,0,0,1,0,2
cannabidiol,0,0,0,2,0,2
cardiac,0,1,0,1,0,2
cardiac/electrodermal recordings,0,1,0,1,0,2
cellectraâ® 2000,1,0,0,1,0,2
cenicriviroc,0,0,0,2,0,2
chest ct,0,2,0,0,0,2
clinical assessment,0,1,0,1,0,2
clinical examination,0,0,0,2,0,2
cobicistat,0,0,0,2,0,2
conjunctival swab,0,1,0,1,0,2
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules",0,0,0,2,0,2
cpap,0,0,0,2,0,2
cumin,0,0,0,2,0,2
cyclosporine,0,0,0,2,0,2
cytokine adsorption,0,0,0,2,0,2
dapagliflozin,0,0,0,2,0,2
darunavir,0,0,0,2,0,2
darunavir/cobicistat,0,0,0,2,0,2
dialysis,1,0,0,1,0,2
dipyridamole,0,0,0,2,0,2
dornase alfa,1,0,0,1,0,2
edp1815,0,0,0,2,0,2
education,0,0,1,1,0,2
eidd-2801,0,0,0,2,0,2
electrodermal recordings,0,1,0,1,0,2
elisa,1,1,0,0,0,2
emotional stimulation,0,1,0,1,0,2
emtricitabine,0,0,0,2,0,2
favipiravir placebo,0,0,0,2,0,2
favipiravir/hydroxychloroquine,0,0,0,2,0,2
file scanning,0,0,0,2,0,2
flow cytometry,0,0,0,2,0,2
fondaparinux,0,2,0,0,0,2
guduchi ghan vati,0,2,0,0,0,2
honey,0,0,0,2,0,2
hormones,1,0,0,1,0,2
hyperbaric oxygen,0,0,0,1,1,2
ibrutinib,0,0,0,2,0,2
ibuprofen,0,0,0,2,0,2
igg test,0,0,0,2,0,2
iloprost,0,0,0,2,0,2
imu-838,0,0,0,2,0,2
ino-4800,1,0,0,1,0,2
iodine,0,0,0,2,0,2
kb109,0,0,0,2,0,2
kb109 / self supportive care (ssc),0,0,0,2,0,2
kg,0,0,0,2,0,2
lanadelumab,0,0,0,2,0,2
ledipasvir,0,1,0,1,0,2
"magpro x100 stimulator, b70 fluid-cooled coil",0,0,0,2,0,2
maraviroc,0,0,0,2,0,2
mechanical ventilation,0,0,0,2,0,2
meditation,0,0,1,1,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-,0,0,1,1,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule,0,0,1,1,0,2
mefloquine,2,0,0,0,0,2
mri,0,0,0,2,0,2
muscle,0,0,0,2,0,2
n-acetylcysteine,0,0,0,2,0,2
nafamostat mesilate,0,0,0,2,0,2
nasal rinse,0,0,0,2,0,2
nigella sativa / black cumin,0,0,0,2,0,2
nutrition,1,0,0,1,0,2
octagam,0,0,0,2,0,2
omega-3,0,0,0,2,0,2
online questionnaires,0,1,0,1,0,2
online support group,1,0,0,1,0,2
ophthalmologic exam,0,0,0,2,0,2
oral polio vaccine,0,0,2,0,0,2
phone call,0,0,0,2,0,2
physical therapy,1,0,0,1,0,2
physiotherapy,0,1,0,1,0,2
povidone-iodine,0,0,0,2,0,2
practice details,0,2,0,0,0,2
pregnant women with laboratory-confirmed 2019-n-cov,0,0,0,2,0,2
preventive information,0,0,2,0,0,2
psychological,1,0,0,1,0,2
pul-042,0,0,0,2,0,2
pyronaridine-artesunate,0,0,0,2,0,2
quality of life,0,0,1,1,0,2
quercetin,0,0,0,2,0,2
radiological,0,0,0,2,0,2
ravulizumab,0,0,0,2,0,2
recombinant new coronavirus vaccine (cho cell) low-dose group,0,0,0,2,0,2
recombinant new coronavirus vaccine (cho cells) high-dose group,0,0,0,2,0,2
recop unit patient,2,0,0,0,0,2
regn10933 / regn10987,0,0,0,2,0,2
regn10933/regn10987 combination therapy,0,0,0,2,0,2
sars-cov-2,0,1,0,1,0,2
sars-cov-2 rs,0,0,0,2,0,2
sars-cov-2 rs/matrix-m1 adjuvant,0,0,0,2,0,2
self supportive care (ssc),0,0,0,2,0,2
self supportive care (ssc) alone,0,0,0,2,0,2
siltuximab,0,0,0,2,0,2
sivomixx,1,0,0,1,0,2
soc / placebo,0,0,0,2,0,2
sofosbuvir/ledipasvir,0,1,0,1,0,2
stool collection,0,0,0,2,0,2
td-0903,0,1,0,1,0,2
tele-yoga therapy,0,2,0,0,0,2
throat swab,0,0,0,2,0,2
tofacitinib,0,0,0,2,0,2
traditional chinese medicine,0,0,0,2,0,2
ultrasonography,0,1,0,1,0,2
vv-ecmo,0,0,0,2,0,2
water,0,1,0,1,0,2
whole exome sequencing,0,0,0,2,0,2
- tocilizumab,1,0,0,0,0,1
-interferon nebulization,0,1,0,0,0,1
"""calm"" is a mindfulness meditation mobile app",0,0,0,1,0,1
": igg, ig m serologies in the amniotoc fluid, the blood cord",0,0,0,1,0,1
[timp-2]*[igfbp-7],0,1,0,0,0,1
0.12% chg oral rinse,0,0,0,1,0,1
0.4ml inj syringe 0.4ml,0,0,0,1,0,1
0.67ml inj syringe,1,0,0,0,0,1
10 to 14 days later,0,0,0,1,0,1
100 mg,0,0,0,1,0,1
1200 mg),0,0,0,1,0,1
14-day schedule,0,0,0,1,0,1
1600 mg),0,0,0,1,0,1
18f-î±vî²6-bp,0,0,1,0,0,1
2.2x10^10vp (qpcr) boost,0,0,0,1,0,1
21 - phase 2,0,0,0,1,0,1
4plants,0,0,1,0,0,1
4plants/azythromycin,0,0,1,0,0,1
5x10^10vp boost (qpcr),0,0,0,1,0,1
6 months later,0,0,0,1,0,1
6 weeks after delivery,0,0,0,1,0,1
a short video intervention,0,0,0,1,0,1
a vignette intervention,0,0,0,1,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level",0,0,1,0,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level/quality of life/questioning exercise habits before/after the covid-19 outbreak in patients with behã§et/fmf.",0,0,1,0,0,1
aã§aã­ palm berry extract - natural product,0,0,0,1,0,1
aapc,0,0,0,1,0,1
aaz covid-19 rapid test,0,0,0,1,0,1
abdominal ultrasound,0,1,0,0,0,1
abpm,0,0,0,1,0,1
abx464,0,0,0,1,0,1
accuchek inform ii platform,0,0,0,1,0,1
"ace inhibitor, angiotensin receptor blocker",0,0,0,1,0,1
ace inhibitor/arb,1,0,0,0,0,1
ace inhibitors/calcium channel blockers,0,1,0,0,0,1
ace/arb,0,0,0,1,0,1
actigraphy,0,0,0,1,0,1
action (tara),0,1,0,0,0,1
activase,0,0,0,1,0,1
active comparator,0,0,0,1,0,1
active covid-19 disease,0,0,0,1,0,1
activity,0,1,0,0,0,1
acute kidney injury,0,1,0,0,0,1
ad5-ncov,0,0,0,1,0,1
adam sensor,0,0,0,1,0,1
adaptation at work score (psas),0,1,0,0,0,1
"adaptive immune response, complement activation,",0,0,0,1,0,1
adenovirus type-5 vectored covid-19 vaccine,1,0,0,0,0,1
adimrsc-2f,0,0,0,1,0,1
admission to icu for covid-19,0,1,0,0,0,1
adsorbed covid-19 (inactivated) vaccine,0,0,0,1,0,1
aerosolized dnase,0,0,0,1,0,1
after-each-case room disinfection,0,1,0,0,0,1
after covid-19 pandemic,0,0,0,1,0,1
after the covid-19 outbreak in patients with behã§et,0,0,1,0,0,1
ag0301-covid19,1,0,0,0,0,1
ag0302-covid19,1,0,0,0,0,1
ai model,1,0,0,0,0,1
airwave oscillometry,0,0,0,1,0,1
airway management during sedation,0,0,0,1,0,1
airway management during sedation/general anesthesia,0,0,0,1,0,1
airway pressure release ventilation,0,1,0,0,0,1
albumine,0,0,0,1,0,1
alexa amazon,0,0,0,1,0,1
all treatment about covid-2019,0,0,0,1,0,1
allocetra-ots,0,0,0,1,0,1
allogeneic,0,0,0,1,0,1
almitrine,0,0,0,1,0,1
alpha one antitrypsin,0,0,0,1,0,1
alum adjuvant,0,0,0,1,0,1
aluminum adjuvant of inactivated sars-cov-2 vaccine,0,0,0,1,0,1
alveolar,0,0,0,1,0,1
ambrisentan,0,0,0,1,0,1
ambulation,0,0,0,1,0,1
amiodarone,0,0,0,1,0,1
ampion,1,0,0,0,0,1
anakinra/osoc,0,0,0,1,0,1
"analysis of cytokine response, innate",0,0,0,1,0,1
"analysis of cytokine response, innate/adaptive immune response, complement activation,/serum neurofilaments as a marker of neurological damage.",0,0,0,1,0,1
ang-3777,0,0,0,1,0,1
anger message,0,1,0,0,0,1
angiography scanner,0,0,0,1,0,1
angiotensin-converting enzyme inhibitors (ace-i)/angiotensin ii receptor blockers (arb),0,1,0,0,0,1
angiotensin ii,0,0,0,1,0,1
angiotensin peptide (1-7) derived plasma,0,0,0,1,0,1
anise,0,0,0,1,0,1
anluohuaxian,0,0,0,1,0,1
anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,0,0,0,1,0,1
anti-sars-cov-2 igt seropositivity,0,1,0,0,0,1
anti-sars-cov-2 igy,0,0,0,1,0,1
anti-sars-cov2 serological controls,0,0,0,1,0,1
anti-sars-cov2 serological controls/serum neutralization,0,0,0,1,0,1
antidiabetic treatment,0,1,0,0,0,1
antioxidants,0,0,0,1,0,1
antirheumatic drugs,0,0,1,0,0,1
antithrombotic therapy (anticoagulant and,0,1,0,0,0,1
antithrombotic therapy (anticoagulant and/or antiplatelet) before admission for covid19,0,1,0,0,0,1
anxiety,0,0,0,1,0,1
anxiety questionnaire,0,0,0,1,0,1
anxiety reduction training,0,0,0,1,0,1
anxiety),0,0,0,1,0,1
any drug used to treat covid-19,0,0,0,1,0,1
apilimod dimesylate,0,0,0,1,0,1
apl-9,0,0,0,1,0,1
apple watch,0,0,0,1,0,1
apps,0,0,0,1,0,1
apremilast,0,0,0,1,0,1
aprepitant injectable emulsion,0,0,0,1,0,1
aprotinin,1,0,0,0,0,1
arb blocker,0,1,0,0,0,1
arbidol hydrochloride/interferon atomization,0,0,0,1,0,1
ardsnet,0,0,0,1,0,1
argatroban,0,0,0,1,0,1
artemesia annua,0,0,0,1,0,1
artemic,0,0,0,1,0,1
artesunate-amodiaquine,0,0,0,1,0,1
asbrip,0,0,0,1,0,1
asc09,0,0,0,1,0,1
asc09f/oseltamivir,0,0,0,1,0,1
ascorbic acid/zinc gluconate,0,0,1,0,0,1
assembled mask,0,0,0,1,0,1
assessing impact of covid19,0,0,1,0,0,1
assessment of cardiovascular diseases,0,0,0,1,0,1
assessment of cardiovascular diseases/cardiovascular risk factors,0,0,0,1,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4,0,0,0,1,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4/6 weeks after delivery,0,0,0,1,0,1
assessment of the sequelae after hospitalization for sars-cov-2,0,0,1,0,0,1
assessment of ventilator-associated pneumonia criteria,0,0,0,1,0,1
assessment),0,0,0,1,0,1
assigned strategies: active choice,0,0,0,1,0,1
assigned strategies: enhanced active choice,0,0,0,1,0,1
assigned strategies: opt-in,0,0,0,1,0,1
asynchronies detection,0,1,0,0,0,1
at-001,0,0,0,1,0,1
at-527,0,0,0,1,0,1
at risk for covid-19 infection,0,0,0,1,0,1
atazanavir,0,0,0,1,0,1
atazanavir/dexamethasone,0,0,0,1,0,1
ati-450,0,0,0,1,0,1
atovaquone,0,0,0,1,0,1
atovaquone/azithromycin,0,0,0,1,0,1
attendance by ambulance crew,0,0,0,1,0,1
attention bias modification (abm),0,1,0,0,0,1
attention placebo,0,0,0,1,0,1
atyr1923,0,0,0,1,0,1
auditory evoked potentials (aep),0,0,0,1,0,1
auricular neuromodulation,0,0,0,1,0,1
auricular percutaneous neurostimulation,0,0,0,1,0,1
autologous non-hematopoietic peripheral blood stem cells (nhpbsc),0,1,0,0,0,1
autopsy,0,1,0,0,0,1
auxora,0,0,0,1,0,1
avdoralimab,0,0,0,1,0,1
avigan,0,0,0,1,0,1
aviptadil,0,0,0,1,0,1
aviptadil/standard care,0,0,0,1,0,1
award,0,0,0,1,0,1
award advice,0,0,0,1,0,1
award/covid-specific advice,0,0,0,1,0,1
ayurvedic kadha,0,1,0,0,0,1
azd1222,0,0,0,1,0,1
azd1656,0,0,0,1,0,1
azoximer bromide,0,0,0,1,0,1
bactek-r,0,0,0,1,0,1
bandebereho fathers',0,0,1,0,0,1
bardoxolone methyl,0,0,0,1,0,1
baricitinib/anakinra,0,0,0,1,0,1
baseline message,0,1,0,0,0,1
basic feedback,0,0,0,1,0,1
bdb-001 injection,0,0,0,1,0,1
beck depression inventory (bdi),0,1,0,0,0,1
behaviour change technique intervention to improve quality of life,0,0,0,1,0,1
bemiparin,0,0,0,1,0,1
berberine,0,1,0,0,0,1
best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
bgb dxp593,0,0,0,1,0,1
bidirectional oxygenation mouthpiece,0,0,0,1,0,1
bio101,0,0,0,1,0,1
biochemical analysis,0,1,0,0,0,1
biological assays in particular on the lipid metabolism,0,1,0,0,0,1
biological sample/clinical data collection,0,0,0,1,0,1
biological test,0,0,0,1,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,0,0,0,1,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,0,0,0,1,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,0,0,0,1,0,1
"biomarker (tropt, myoglobin, ck, ck-mb, ldh, d-dimer, crp, pct)",0,0,0,1,0,1
biomarkers expression,0,0,0,1,0,1
biosensor,0,0,0,1,0,1
biovitals,0,0,0,1,0,1
bivalirudin,0,0,0,1,0,1
bld-2660,0,0,0,1,0,1
blink,0,0,0,1,0,1
blink/masseter inhibitory reflex,0,0,0,1,0,1
blood collection on their first consultation/10 to 14 days later,0,0,0,1,0,1
blood d-dimer assay,0,1,0,0,0,1
blood draw,0,0,0,1,0,1
blood group determination,0,0,0,1,0,1
blood sample for seroepidemiological investigation,0,0,0,1,0,1
"blood tests sputum, nasal lavage",0,0,0,1,0,1
"blood tests sputum, nasal lavage/brushing",0,0,0,1,0,1
blood/derivatives,0,0,0,1,0,1
bms-986253,0,0,0,1,0,1
bnt162a1,0,0,0,1,0,1
bnt162b3,0,0,0,1,0,1
bnt162c2,0,0,0,1,0,1
brain mri,0,0,0,1,0,1
brazilian green propolis extract (epp-af),0,1,0,0,0,1
breath biopsy face masks with removable filters,0,0,0,1,0,1
breath biopsy face masks with removable filters/fitted pva strip,0,0,0,1,0,1
breath test/cheek swab,0,0,0,1,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation",0,0,0,1,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation/ambulation",0,0,0,1,0,1
brequinar,0,0,0,1,0,1
brief psychiatric rating scale,0,0,0,1,0,1
bromelain,0,0,0,1,0,1
bromhexine oral tablet and/or hydroxychloroquine tablet,0,0,0,1,0,1
broncho-vaxomâ®,0,0,0,1,0,1
brushing,0,0,0,1,0,1
btl-tml-covid,0,0,0,1,0,1
bucillamine,0,0,1,0,0,1
butterfly,0,0,0,1,0,1
bva-100,0,0,0,1,0,1
c-reactive protein,0,0,0,1,0,1
c21,0,0,0,1,0,1
c3,0,1,0,0,0,1
c3/ holter monitor,0,1,0,0,0,1
cag,0,0,0,1,0,1
calcium channel blockers,0,1,0,0,0,1
cambridge validated viral detection,0,0,0,1,0,1
candesartan,0,0,0,1,0,1
cardiac surgery,0,0,0,1,0,1
cardiology clinical consultations,0,0,0,1,0,1
cardiopulmonary resuscitation,0,0,0,1,0,1
cardiovascular risk factors,0,0,0,1,0,1
care as usual,0,0,1,0,0,1
caring contacts,0,0,0,1,0,1
carotid artery reactivity testing,1,0,0,0,0,1
case fatality rate,0,1,0,0,0,1
cash transfer,1,0,0,0,0,1
castem,0,0,0,1,0,1
ccp,0,0,0,1,0,1
cd24fc,1,0,0,0,0,1
cell therapy protocol 1,0,0,0,1,0,1
cell therapy protocol 2,0,0,0,1,0,1
cellular response,0,0,0,1,0,1
cellulose-containing placebo capsules,0,0,0,1,0,1
centricyte 1000,0,0,1,0,0,1
centrum adult (under 50) multivitamin,0,0,1,0,0,1
cerc-002,0,0,0,1,0,1
cerebral compliance,0,1,0,0,0,1
cerebral compliance/hemodynamics monitoring,0,1,0,0,0,1
certified cloth face mask,0,0,1,0,0,1
certified cloth face mask/preventive information,0,0,1,0,0,1
change in preference to surgery under covid-19 pandemic.,0,1,0,0,0,1
chat-based instant messaging support,1,0,0,0,0,1
chat-based support,0,0,0,1,0,1
cheek swab,0,0,0,1,0,1
chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
chest ct scan,0,0,0,1,0,1
chest mri,0,0,0,1,0,1
chest x-ray,0,0,0,1,0,1
chiropractic care (more than one visit),0,1,0,0,0,1
chiropractic care (one visit),0,1,0,0,0,1
chlorhexidine,0,0,0,1,0,1
chlorine dioxide,0,0,0,1,0,1
choice of assignment: active choice,0,0,0,1,0,1
choice of assignment: enhanced active choice,0,0,0,1,0,1
choice of assignment: opt-in,0,0,0,1,0,1
chx0.12,0,0,0,1,0,1
chx0.12/cpc0.05 oral rinse (perioaidactive control),0,0,0,1,0,1
cig axial,1,0,0,0,0,1
cig tilted,1,0,0,0,0,1
citrox,0,0,0,1,0,1
ck0802,0,0,0,1,0,1
clarithromycin,0,0,0,1,0,1
clevudine,0,0,0,1,0,1
clinical data collection,0,0,0,1,0,1
clinical diagnosis of covid-19 by a health care professional,0,0,0,1,0,1
clinical features,0,0,0,1,0,1
clinical interview,0,0,0,1,0,1
clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
clinical testing of subjects,0,0,0,1,0,1
"clinical, laboratory",0,0,0,1,0,1
"clinical, laboratory/imaging characteristics of pneumonia",0,0,0,1,0,1
clinico-biological parameters in routine care,0,0,0,1,0,1
clofazimine,0,0,0,1,0,1
closed-loop control of oxygen supplementation by o2matic,0,1,0,0,0,1
clungene rapid test cassette,0,0,0,1,0,1
cns magnetic resonance imaging (mri) imaging,0,0,0,1,0,1
cognitive,0,0,0,1,0,1
colchicine pill,0,0,0,1,0,1
colchicine/herbal phenolic monoterpene fractions,0,0,0,1,0,1
colchicine/symptomatic treatment (paracetamol),0,0,0,1,0,1
colgate periogard mouthwash,0,0,1,0,0,1
colgate peroxyl mouthwash,0,0,1,0,0,1
colgate total mouthwash,0,0,1,0,0,1
collagen-polyvinylpyrrolidone,0,0,0,1,0,1
collection of blood samples in order to create a biocollection,0,0,0,1,0,1
collection of odour samples,0,0,0,1,0,1
collection of swabs,0,0,0,1,0,1
combination,1,0,0,0,0,1
combination of oral polio vaccine/na-831,0,0,1,0,0,1
communication type,0,1,0,0,0,1
community-driven messages to promote covid-19 testing,0,0,1,0,0,1
community health worker support,0,0,1,0,0,1
community health workers.,0,0,0,1,0,1
community interest message,0,1,0,0,0,1
comparable placebo,0,0,1,0,0,1
comparable placebo of drug,0,0,1,0,0,1
comparable placebo of oral polio vaccine,0,0,1,0,0,1
compare the difference in respiratory rate between h0,0,0,0,1,0,1
complement dosage,0,0,0,1,0,1
complete thrombophilic profile testing by multiplex pcr,0,0,0,1,0,1
complex diagnostic panel,0,0,1,0,0,1
comprehensive treatment,0,0,0,1,0,1
conestat alfa,0,0,0,1,0,1
conjunctival swab/nasopharyngeal swab,0,0,0,1,0,1
connected devices measurements,0,0,0,1,0,1
connor-davidson resilience scale 10 items (cd-risc 10),0,0,0,1,0,1
contain covid anxiety ssi,0,0,0,1,0,1
continuation of acei,0,0,0,1,0,1
continuation of acei/arb,0,0,0,1,0,1
continuation of arb,0,0,1,0,0,1
continuation of ras blocker,0,0,0,1,0,1
continuous positive airway pressure,0,0,0,1,0,1
continuous renal replacement therapy,0,0,0,1,0,1
control message,0,1,0,0,0,1
control swab,0,0,0,1,0,1
convalscent plasma,0,0,0,1,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,",0,0,0,1,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)",0,0,0,1,0,1
conventional therapy first,1,0,0,0,0,1
copan swabbing,0,0,0,1,0,1
copan swabbing/blood sample collection,0,0,0,1,0,1
coping strategies video,0,0,0,1,0,1
core warming,0,0,0,1,0,1
coronavirus disease 2019,0,0,0,1,0,1
corticosteroids,0,0,0,1,0,1
cosh self-help smoking cessation booklet,0,0,0,1,0,1
cospherunate,0,0,1,0,0,1
cospherunate/azythromycine,0,0,1,0,0,1
cospherunate/phytomedicine/azythromycien,0,0,1,0,0,1
couples' group education,0,0,1,0,0,1
covi-guard,0,0,0,1,0,1
covicu,0,0,0,1,0,1
covid-19 / patients,1,0,0,0,0,1
covid-19 androgen sensitivity test (covast),0,0,1,0,0,1
covid-19 antibody testing,0,0,0,1,0,1
covid-19 antigen,0,0,0,1,0,1
"covid-19 antigen/antibody rapid testing, mobile device image capture/telemedicine support",0,0,0,1,0,1
covid-19 convalescent plasma (ccp)/standard of care (soc),0,0,0,1,0,1
covid-19 diagnostic test,0,0,0,1,0,1
covid-19 experience surveys,0,0,0,1,0,1
covid-19 facility,0,1,0,0,0,1
covid-19 infection,0,0,0,1,0,1
covid-19 infection status,0,0,0,1,0,1
covid-19 infection will be conducted.,0,0,0,1,0,1
covid-19 patients,0,0,0,1,0,1
covid-19 positive pregnant women,0,1,0,0,0,1
covid-19 positive via testing,0,0,0,1,0,1
covid-19 presto test,0,0,0,1,0,1
covid-19 related health warning leaflet,0,0,0,1,0,1
covid-19 survey,0,0,0,1,0,1
covid-19 swab,0,0,0,1,0,1
covid-19 treatment,0,0,0,1,0,1
covid-19 treatments,0,1,0,0,0,1
covid-19/ observational,0,0,0,1,0,1
covid-19/intensive care,0,1,0,0,0,1
covid-specific advice,0,0,0,1,0,1
covid-surgres questionaire,0,1,0,0,0,1
covid 19 diagnostic test,1,0,0,0,0,1
covid 19 impact,0,1,0,0,0,1
covid19 vaccine,0,0,0,1,0,1
covidseq test,0,0,1,0,0,1
covsurf drug delivery system,0,0,0,1,0,1
covx,0,1,0,0,0,1
cpc0.05 oral rinse (perioaidactive control),0,0,0,1,0,1
cpi-006,0,0,0,1,0,1
crisis intervention therapy,0,0,1,0,0,1
crizanlizumab,0,0,0,1,0,1
cross-sectional observational study,0,1,0,0,0,1
cross-sectional study investigating the association of npis with mental health,0,1,0,0,0,1
cross sectional study using scientifically validated psychometric scales,0,1,0,0,0,1
csvf,0,0,1,0,0,1
ctus examination,0,0,0,1,0,1
cupping,0,0,0,1,0,1
current care per ucla treating physicians,0,0,0,1,0,1
cvncov vaccine,0,0,0,1,0,1
cyp-001,0,0,0,1,0,1
cytokines,0,0,0,1,0,1
cytokines measurement,0,0,0,1,0,1
d,0,0,0,1,0,1
d followed by enoxaparin,0,0,0,1,0,1
daily coping toolkit,0,0,0,1,0,1
daily monitoring,0,0,0,1,0,1
daily room disinfection,0,1,0,0,0,1
daily syndromic surveillance,0,0,1,0,0,1
dalargin,1,0,0,0,0,1
dalteparin,0,1,0,0,0,1
danoprevir,0,1,0,0,0,1
danoprevir/ritonavir,0,1,0,0,0,1
dapansutrile capsules,0,0,0,1,0,1
das181,0,1,0,0,0,1
dass-21 instrument (depression,0,0,0,1,0,1
dass-21 instrument (depression/anxiety),0,0,0,1,0,1
data,0,0,0,1,0,1
data collection from blood draw,0,0,0,1,0,1
data collection from lumbar puncture,0,0,0,1,0,1
data collection from medical files,0,0,0,1,0,1
data collection up to 1 year,0,0,0,1,0,1
data collection/clinical testing of subjects,0,0,0,1,0,1
data collection/rhinopharyngeal swab,0,1,0,0,0,1
data collection: clinical care assessments,0,0,1,0,0,1
data monitoring for 48h within the first 12 hours of admission for covid-19,0,0,0,1,0,1
data registry,0,0,0,1,0,1
"data research, database analysis",0,1,0,0,0,1
day,0,0,0,1,0,1
death with routine,1,0,0,0,0,1
decitabine,0,0,0,1,0,1
deferoxamine,0,0,0,1,0,1
defibrotide,0,0,0,1,0,1
defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
degarelix,0,0,0,1,0,1
deglycyrrhizinated licorice,0,0,0,1,0,1
demographic characteristics,0,1,0,0,0,1
depression scale,0,0,0,1,0,1
"depression,",0,0,0,1,0,1
"depression, anxiety",0,0,0,1,0,1
"depression, anxiety/stress scale",0,0,0,1,0,1
derivatives.,0,0,0,1,0,1
desidustat,0,0,0,1,0,1
device used to record voice for screening,0,0,0,1,0,1
device),0,0,0,1,0,1
dexamethasone/hydroxychloroquine,0,0,0,1,0,1
dexcom,0,0,0,1,0,1
dfv890,0,0,0,1,0,1
diabetes type 2,1,0,0,0,0,1
diagnosed with covid-19,0,0,0,1,0,1
"diagnosis of sars-cov2 by rt-pcr/: igg, ig m serologies in the amniotoc fluid, the blood cord/the placenta",0,0,0,1,0,1
diagnostic,0,0,0,1,0,1
diagnostic examination for venous thromboembolism,0,0,0,1,0,1
diagnostic laboratory biomarker analysis,0,0,0,1,0,1
diagnostic test,0,1,0,0,0,1
diagnostic test covid-19,0,0,0,1,0,1
diagnostic test for detection of sars-cov-2,0,0,1,0,0,1
diagnostic test for sars-cov2 for patients,0,0,0,1,0,1
diagnostic test for sars-cov2 for patients/health staff,0,0,0,1,0,1
diagnostic tests for covid-19 infection,0,0,0,1,0,1
dialectical behavioral therapy (dbt) skills,0,0,0,1,0,1
diet tracking,0,0,0,1,0,1
"dietary counselling on food groups according to iyc feeding practices, who",0,0,0,1,0,1
dietary supplement containing resistant starch,0,0,0,1,0,1
differences in triage,0,1,0,0,0,1
difficulties lived by disabled children's parents in the period of covid-19 pandemic,0,0,0,1,0,1
dig axial,1,0,0,0,0,1
dig tilted,1,0,0,0,0,1
digital cardiac counseling,0,0,0,1,0,1
digital health online platform,0,0,0,1,0,1
diovan,0,0,0,1,0,1
direct antigen tests for covid-19,0,1,0,0,0,1
direct laryngoscope,1,0,0,0,0,1
discontinuation of acei,0,0,0,1,0,1
discontinuation of acei/arb,0,0,0,1,0,1
discontinuation of arb,0,0,1,0,0,1
discontinuation of ras blocker,0,0,0,1,0,1
discussion board for social support,0,0,0,1,0,1
discussion board for social support /basic feedback,0,0,0,1,0,1
discussion board for social support/personalized feedback,0,0,0,1,0,1
distance learning,0,0,1,0,0,1
dlco,0,0,0,1,0,1
dociparastat sodium,0,0,0,1,0,1
doctor spot,0,0,0,1,0,1
doppler echo,0,0,0,1,0,1
double-blind nt-i7,0,0,0,1,0,1
drugs,0,0,0,1,0,1
drugs/supportive care,0,0,0,1,0,1
duplex ultrasound/computed tomography angiography,0,1,0,0,0,1
dur-928,0,0,0,1,0,1
during covid-19 pandemic,0,0,0,1,0,1
dutasteride,0,0,0,1,0,1
ðžxygen therapy,0,0,0,1,0,1
e-psychotherapy,0,0,0,1,0,1
early-dexamethasone,0,0,0,1,0,1
earsats pulse oximeter probe,0,0,0,1,0,1
ec-18,0,0,0,1,0,1
ecco2r,0,0,0,1,0,1
ecg-holter,0,0,0,1,0,1
echo-doppler,0,0,0,1,0,1
echocardiogram,0,0,0,1,0,1
economic benefit message,0,1,0,0,0,1
economic freedom message,0,1,0,0,0,1
eculizumab,0,0,0,1,0,1
education sessions,0,0,0,1,0,1
educational meetings,0,1,0,0,0,1
educational meetings/visual prompts,0,1,0,0,0,1
educational video,0,0,0,1,0,1
eeg,0,0,0,1,0,1
eit-group,0,0,0,1,0,1
elective cancer surgery,0,0,0,1,0,1
"electrocardiogram, telemetry, echocardiogram, laboratory values",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography/clinico-biological parameters in routine care",0,0,0,1,0,1
electrolytes,1,0,0,0,0,1
electronic health record review,0,0,0,1,0,1
elisa/rapid test to detect antibodies against covid-19,1,0,0,0,0,1
eltrombopag,0,0,0,1,0,1
emapalumab,0,0,0,1,0,1
embarrassment message,0,1,0,0,0,1
emergency laparotomy,0,1,0,0,0,1
emergency surgery,0,1,0,0,0,1
emotional support plan,0,0,0,1,0,1
emtricitabine/tenofovir,0,0,0,1,0,1
emtricitabine/tenofovir disoproxil,0,0,0,1,0,1
endoscopic intervention,0,1,0,0,0,1
endoscopic management according to standard of care,0,1,0,0,0,1
endoscopy,0,1,0,0,0,1
enhanced hygiene measures,1,0,0,0,0,1
enoxaparin/lovenox,0,0,0,1,0,1
enriched survey feedback,0,0,0,1,0,1
ensifentrine,0,0,0,1,0,1
ent exam,0,0,0,1,0,1
environmental exposure,0,0,0,1,0,1
environmental exposure/clinical features,0,0,0,1,0,1
enzalutamide,0,0,0,1,0,1
ep,0,0,0,1,0,1
epds (edinburgh postnatal depression scale),1,0,0,0,0,1
epic risk score display,0,0,0,1,0,1
epidemiological,0,1,0,0,0,1
epidemiological/demographic characteristics,0,1,0,0,0,1
epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),1,0,0,0,0,1
escin,0,0,0,1,0,1
essential oils,0,1,0,0,0,1
estradiol,0,0,0,1,0,1
etoposide,0,0,0,1,0,1
euroimmun assay,0,0,0,1,0,1
evaluate hacor score effectivity in this patients,0,0,0,1,0,1
evaluation,0,0,0,1,0,1
evaluation of changes in the diagnostic-therapeutic pathway,0,1,0,0,0,1
"evaluation of clinical, instrumental",0,0,0,1,0,1
"evaluation of clinical, instrumental/laboratory diagnostics tests",0,0,0,1,0,1
evaluation of skin microvascular flow,0,0,0,1,0,1
evaluation of skin microvascular flow/reactivity,0,0,0,1,0,1
evaluation of the epidemiological characteristics of coronavirus infection (sars-cov-2),0,0,0,1,0,1
evaluation of the ferritin,0,0,0,1,0,1
even birth year intervention groups,0,0,0,1,0,1
examinations for the research:,0,0,0,1,0,1
examine the impact of covid-19 during pregnancy,0,0,0,1,0,1
exercise booklet,0,0,0,1,0,1
exercise program,0,0,0,1,0,1
exhaled breath sampling,0,0,0,1,0,1
exo 1 inhalation,0,0,1,0,0,1
exo 2 inhalation,0,0,1,0,0,1
experiences of health care professionals working in intensive care units during the covid-19 pandemic,0,0,0,1,0,1
experimental group,0,0,0,1,0,1
experimental: questionnaire without precaution information,0,1,0,0,0,1
experts consensus,1,0,0,0,0,1
exposure surveys,1,0,0,0,0,1
exposure to the dutch measures due to the covid-19 pandemic.,0,0,0,1,0,1
extracorporeal blood purification using the oxirisâ® (an69st) hemofilter,0,0,0,1,0,1
extracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
extracorporeal membrane oxygenation,0,0,0,1,0,1
f-652,0,0,0,1,0,1
face mask sampling,0,0,0,1,0,1
facial fractures reduction,0,1,0,0,0,1
facial fractures reduction/osteosynthesis,0,1,0,0,0,1
family nurture intervention (fni),0,0,0,1,0,1
farmalarm,0,1,0,0,0,1
favipiravir / standard care,1,0,0,0,0,1
favipiravir/azithromycin,0,0,0,1,0,1
favipiravir/chloroquine,0,0,0,1,0,1
favipiravir/nitazoxanide,0,0,0,1,0,1
favipiravir/tocilizumab,0,0,0,1,0,1
favorable outcome,0,1,0,0,0,1
fecal,0,0,0,1,0,1
feces samples (covi-biome ancillary study),0,0,0,1,0,1
fenofibrate,0,0,1,0,0,1
fibrin generation markers assays,0,0,0,1,0,1
filmarray pneumonia,0,1,0,0,0,1
filtration test,0,1,0,0,0,1
fingerstick,0,0,0,1,0,1
fingertip tests for poc assays,0,0,0,1,0,1
fingolimod,0,0,0,1,0,1
fisetin,0,0,1,0,0,1
fit test,0,1,0,0,0,1
fitted pva strip,0,0,0,1,0,1
flow controlled ventilation (evone-ventilator),0,0,0,1,0,1
fluoxetine,0,0,0,1,0,1
fluvoxamine,1,0,0,0,0,1
fmd,0,0,0,1,0,1
fmf.,0,0,1,0,0,1
folic acid,1,0,0,0,0,1
follow up,0,0,0,1,0,1
fondapariniux,0,0,0,1,0,1
formoterol,0,0,0,1,0,1
freestyle libre 14 day cgm system,0,0,0,1,0,1
fsfi survey,0,1,0,0,0,1
functional mri,0,0,0,1,0,1
further processing of health data,0,0,0,1,0,1
fuzheng huayu,0,0,0,1,0,1
gad-7 (7-item generalized anxiety disorder),0,0,0,1,0,1
gad-7 (general anxiety disorder) scale,1,0,0,0,0,1
gad-7 general anxiety disorder scale,0,0,0,1,0,1
gam-covid-vac lyo,0,1,0,0,0,1
gamification,0,0,0,0,1,1
gammacoreâ® (vagus nerve stimulation),0,0,0,1,0,1
gammacoreâ® sapphire (non-invasive vagus nerve stimulator),0,0,0,1,0,1
gamunex-c,0,0,0,1,0,1
ganovo,0,1,0,0,0,1
ganovo/ritonavir//-interferon nebulization,0,1,0,0,0,1
"garadacimab, factor xiia antagonist monoclonal antibody",0,0,0,1,0,1
gargle,0,0,0,1,0,1
gas exchange measurement,0,1,0,0,0,1
gas exchanges at different peep,0,1,0,0,0,1
gastrointestinal endoscopy,0,1,0,0,0,1
gc4419,0,0,0,1,0,1
gc5131,0,0,0,1,0,1
general anesthesia,0,0,0,1,0,1
general health education,0,0,0,1,0,1
general public cohort,0,0,0,1,0,1
generalized anxiety disorder-7 (gad-7),0,1,0,0,0,1
gimsilumab,0,0,0,1,0,1
global longitudinal strain,0,0,0,1,0,1
global survey,0,0,1,0,0,1
gloves,0,1,0,0,0,1
gls-1200,0,0,0,1,0,1
glycaemic levels,0,0,0,1,0,1
glycine,0,0,0,1,0,1
glycosylated ferritin by standard approved serological tests,0,0,0,1,0,1
go2 peep mouthpiece,0,0,0,1,0,1
"gps reports of potential patient safety incidents, non-covid-19 related",0,0,0,1,0,1
grad-cov2,0,0,0,1,0,1
grandiosity subscales,0,0,0,1,0,1
group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,0,0,0,1,0,1
group1,0,0,0,1,0,1
guided online support program,0,0,0,1,0,1
guilt message,0,1,0,0,0,1
gustatory tests,0,0,0,1,0,1
gx-19,0,0,0,1,0,1
h12 of the initiation of morphine between the control,0,0,0,1,0,1
hads,0,0,0,1,0,1
health-related quality of life,0,0,0,1,0,1
health care worker survey,0,0,0,1,0,1
health enhancement program,0,0,0,1,0,1
health literacy,0,0,0,1,0,1
health staff,0,0,0,1,0,1
health warning leaflet,0,0,0,1,0,1
healthy lifestyle advise,0,0,0,1,0,1
healthy minds program foundations training,0,0,0,1,0,1
hemodynamics changes at different peep,0,1,0,0,0,1
hemodynamics monitoring,0,1,0,0,0,1
herbal phenolic monoterpene,0,0,0,1,0,1
high-titer convalescent covid-19 plasma (ccp1),0,0,0,1,0,1
high dose radiation 100 cgy,0,0,0,1,0,1
high flow nasal cannula (hfnc),0,0,0,1,0,1
high flow nasal cannula device,0,1,0,0,0,1
high flow nasal cannula hfnc,0,0,0,1,0,1
high intensity interval training group,1,0,0,0,0,1
high peep with end inspiratory pause,0,0,0,1,0,1
high peep without end inspiratory pause,0,0,0,1,0,1
holter monitor,0,1,0,0,0,1
home-cov rule implementation,0,1,0,0,0,1
home-use test,0,0,0,1,0,1
home care monitoring,0,0,0,0,1,1
home pulse oximetry monitoring,0,1,0,0,0,1
home sleep apnea testing,1,0,0,0,0,1
home sleep apnea testing/in-hospital polysomnography,1,0,0,0,0,1
hope intervention,1,0,0,0,0,1
hospital acquired infection,0,0,0,1,0,1
hospital admission,0,0,0,1,0,1
hospital anxiety,0,0,0,1,0,1
hospital anxiety/depression scale,0,0,0,1,0,1
hospitalized children with covid19,0,0,0,1,0,1
human amniotic fluid,0,0,0,1,0,1
human cord tissue mesenchymal stromal cells,0,0,0,1,0,1
human milk donors,0,0,0,1,0,1
hydrocortisone,1,0,0,0,0,1
hydrogen oxygen generator with nebulizer,0,1,0,0,0,1
hydroxychloroquine / oxygen,0,1,0,0,0,1
hydroxychloroquine/azithromycin/ tocilizumab,1,0,0,0,0,1
hydroxychloroquine/clindamycin,0,1,0,0,0,1
hydroxychloroquine/clindamycin/primaquine,0,1,0,0,0,1
hydroxychloroquine/doxycycline,0,1,0,0,0,1
hydroxychloroquine/lopinavir/ritonavir,0,0,0,1,0,1
hydroxychloroquine/placebo,0,0,0,0,1,1
hydroxyvitamin,0,0,0,1,0,1
hypertension,1,0,0,0,0,1
hypothermia via cooling machine- arctic sun 5000,0,0,0,1,0,1
icatibant,0,0,0,1,0,1
icosapent ethyl,0,0,0,1,0,1
icu recovery,0,0,0,1,0,1
icu recovery / physical therapy,0,0,0,1,0,1
icu treatment,0,0,0,1,0,1
id now vs. accula,0,0,0,1,0,1
ier-r (posttraumatic stress),0,0,0,1,0,1
ifx-1,0,0,0,1,0,1
igg sars cov 2 antibodies,1,0,0,0,0,1
igg sars cov2,1,0,0,0,0,1
igg/igm rapid test,0,0,0,1,0,1
igiv,0,0,0,1,0,1
igm test,0,0,1,0,0,1
imaging,0,0,0,1,0,1
imaging by thoracic scanner,1,0,0,0,0,1
imaging characteristics of pneumonia,0,0,0,1,0,1
"imaging, blood tests",0,1,0,0,0,1
imm-101,0,0,0,1,0,1
immunfluorescence,0,0,0,1,0,1
immunofree tablets,0,0,0,1,0,1
immunofree tablets/reginmune capsule,0,0,0,1,0,1
immunoglubulins,0,0,0,1,0,1
immunological,0,0,0,1,0,1
immunosuppressive,0,0,0,1,0,1
immunosuppressive agents,0,0,0,1,0,1
impact event score,0,0,0,1,0,1
impact of event scale-revised,0,0,0,1,0,1
in-hospital mortality rate,0,1,0,0,0,1
inactivated vaccine,0,0,0,1,0,1
indian costus,0,0,0,1,0,1
indirect calorimetry,0,0,0,1,0,1
individualized-chinese herbal medicine,0,0,0,1,0,1
indomethacin,0,0,0,1,0,1
infectious disease,0,0,0,1,0,1
infectious disease/cardiology clinical consultations,0,0,0,1,0,1
inflammatory cytokines,0,0,0,1,0,1
inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
infliximab,0,0,0,1,0,1
informed consent,0,0,0,1,0,1
injection,0,0,0,1,0,1
inm005,0,0,0,1,0,1
inopulse,0,0,0,1,0,1
insulin,0,0,0,1,0,1
intensive care,0,1,0,0,0,1
interferon-î² 1a,0,0,1,0,0,1
interleuken 6,0,0,0,1,0,1
intermediate dose enoxaparin/ unfractionated heparin,0,0,0,1,0,1
intermittent,1,0,0,0,0,1
internet-based cognitive behavioral therapy,0,0,1,0,0,1
internet-based self-help,0,0,0,1,0,1
internet-based self-help after 3 weeks,0,0,0,1,0,1
internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1,0,0,0,0,1
intervention app,0,1,0,0,0,1
intervention group coronacope,0,0,0,1,0,1
intervention group_rehabilitation program,0,0,0,1,0,1
intervention program,0,0,0,1,0,1
interventional groups,0,0,0,1,0,1
interview by psychologists,0,0,0,1,0,1
intracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
intramuscular vaccine,1,0,0,0,0,1
intraosseous,0,1,0,0,0,1
intravenous,0,1,0,0,0,1
intravenous drug,0,0,0,1,0,1
invasive mechanical ventilation,0,0,0,1,0,1
invasive mechanical ventilation using the unisabana-herons ventilator during 24 hours,0,1,0,0,0,1
investigation of smell,0,0,0,1,0,1
investigation of smell/taste disorders,0,0,0,1,0,1
investigation of the prevalence of test positivity,0,0,0,1,0,1
ion mobility spectrometry (ims),0,0,0,1,0,1
iota-carrageenan,0,0,0,1,0,1
iota carrageenan,1,0,0,0,0,1
ip-10,0,1,0,0,0,1
isoflurane inhalant product,0,0,0,1,0,1
itolizumab,0,1,0,0,0,1
its,0,0,0,1,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg,0,1,0,0,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care.,0,1,0,0,0,1
ivermectin / chloroquine,0,0,0,1,0,1
ivermectin / doxycycline,0,1,0,0,0,1
ivermectin / doxycycline / placebo,0,0,1,0,0,1
ivermectin / placebo,0,0,1,0,0,1
ivermectin/doxycycline,0,1,0,0,0,1
ivig,0,0,0,1,0,1
kamada anti-sars-cov-2,0,0,0,1,0,1
kelea water,0,0,0,1,0,1
ketamine,0,0,0,1,0,1
ketogenic diet,0,0,0,1,0,1
ketotifen,0,1,0,0,0,1
kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
kg once daily,0,1,0,0,0,1
kir phenotype evaluation,0,0,0,1,0,1
"knowledge, attitude, practice, awareness, preference",0,1,0,0,0,1
kundalini yoga,0,0,0,1,0,1
kundalini yoga/anxiety reduction training,0,0,0,1,0,1
laboratory,0,0,0,1,0,1
laboratory analyses,0,0,0,1,0,1
laboratory diagnostics tests,0,0,0,1,0,1
laboratory test positive for sars-cov-2 virus,0,0,0,1,0,1
labs,0,0,0,1,0,1
lactobaciltus rhamnosus gg,0,0,0,1,0,1
lambda 180 mcg s.c,0,0,0,1,0,1
laryngoscopy,0,0,0,1,0,1
lateral position (left,0,0,0,1,0,1
lateral position (left/right lateral decubitus),0,0,0,1,0,1
lau-7b,0,0,0,1,0,1
leaf-4l6715,0,0,0,1,0,1
leaf-4l7520,0,0,0,1,0,1
leflunomide,0,0,0,1,0,1
let it out (lio)-c,1,0,0,0,0,1
leukapheresis,0,0,0,1,0,1
levamisole,0,0,0,1,0,1
levamisole / budesonide/formoterol,0,0,0,1,0,1
levilimab,1,0,0,0,0,1
liberase enzyme,0,0,1,0,0,1
licorice extract,0,0,0,1,0,1
lifestyle change promotion program,0,0,0,1,0,1
lifestyle habits,0,1,0,0,0,1
limbix spark,0,0,0,1,0,1
linagliptin,0,0,0,1,0,1
linagliptin 5 mg,0,0,0,1,0,1
liposomal,0,1,0,0,0,1
liver,0,0,1,0,0,1
lock-down,0,1,0,0,0,1
lock-down/social distancing,0,1,0,0,0,1
longitudinally,0,0,0,1,0,1
lopinavir/ ritonavir,0,0,0,1,0,1
lopinavir/ ritonavir placebo,0,0,0,1,0,1
lopinavir/ritonavir / hydoxychloroquine,0,0,0,1,0,1
losmapimod,0,0,0,1,0,1
lovenox,0,0,0,1,0,1
low dose radiation 35 cgy,0,0,0,1,0,1
low peep - fio2 high,0,0,0,1,0,1
low peep - fio2 low,0,0,0,1,0,1
low/upper respiratory tract sample,0,0,0,1,0,1
lung ct scan analysis in covid-19 patients,0,0,0,1,0,1
lung function test,0,0,1,0,0,1
lung function tests,0,0,0,1,0,1
lung impedance,0,0,0,1,0,1
lung mechanics at different peep,0,1,0,0,0,1
lung ultrasound (lus),0,0,0,1,0,1
lung ultrasound use in patients hospitalized with covid,0,0,0,1,0,1
lv-smenp-dc vaccine,0,0,0,1,0,1
lv-smenp-dc vaccine/antigen-specific ctls,0,0,0,1,0,1
ly3127804,1,0,0,0,0,1
ly3832479,0,0,0,1,0,1
m-m-r ii â® vaccine,0,0,0,1,0,1
m5049,0,0,0,1,0,1
machine learning model,0,1,0,0,0,1
magec spine rod,0,0,0,1,0,1
magnetic resonance imaging,0,0,0,1,0,1
magnetic resonance spectroscopy (mrs).,0,0,0,1,0,1
maintenance,0,0,0,1,0,1
makair,0,0,0,1,0,1
management of covid-19,0,0,0,1,0,1
management strategy of outpatient with mild to moderate sars-cov-2 pneumonia,0,1,0,0,0,1
manremyc,0,0,0,1,0,1
marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol),0,0,0,1,0,1
mas825,0,0,0,1,0,1
"masimo, lidco",0,0,0,1,0,1
maslach burnout inventory (mbi),0,1,0,0,0,1
masseter inhibitory reflex,0,0,0,1,0,1
massive parallel sequencing of host genome,0,0,0,1,0,1
maternal stress,0,0,0,1,0,1
maximal effort test,0,0,0,1,0,1
mcc ims,0,1,0,0,0,1
mcgrath videolaryngoscope,1,0,0,0,0,1
measles-mumps-rubella vaccine,0,0,0,1,0,1
measurement of circulating sflt1 concentration,0,0,0,1,0,1
mechanical trombectomy,0,1,0,0,0,1
media intervention,0,0,0,1,0,1
medical record review - inpatient treatment,0,0,0,1,0,1
meditation therapy,0,0,0,1,0,1
meditation/anxiety reduction training,0,0,0,1,0,1
medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule,0,0,0,1,0,1
mefloquine/azithromycin/ tocilizumab,1,0,0,0,0,1
melatonin intravenous,0,0,0,1,0,1
melphalan,0,0,0,1,0,1
menacwy,1,0,0,0,0,1
menacwy vaccine,0,0,0,1,0,1
mencare,0,0,1,0,0,1
mencare//bandebereho fathers'/couples' group education,0,0,1,0,0,1
mental well-being,0,0,1,0,0,1
meplazumab,0,0,0,1,0,1
merimepodib,0,0,0,1,0,1
mesenchymal stem cell,0,0,0,1,0,1
mesenchymal stromal cell-based therapy,0,0,0,1,0,1
messaging,0,1,0,0,0,1
metabolic cofactors supplementation,0,0,0,1,0,1
metabolic cofactors supplementation/hydroxychloroquine,0,0,0,1,0,1
metabolomic,0,0,0,1,0,1
metenkefalin,1,0,0,0,0,1
metenkefalin / tridecactide,1,0,0,0,0,1
methylene blue,0,0,0,1,0,1
methylene blue/ vitamin c/n-acetyl cysteine,0,0,0,1,0,1
methylprednisolone injectable product,0,0,0,1,0,1
mf59 adjuvanted sars-cov-2 sclamp vaccine,0,0,0,1,0,1
mhealth assessments,0,0,0,1,0,1
microscopy of defined brain regions on autopsy specimens,0,0,0,1,0,1
mindfullness training,0,1,0,0,0,1
mindfulness based intervention,0,1,0,0,0,1
mindfulness session(s),0,0,0,1,0,1
minimal attention control intervention,0,0,0,1,0,1
miniprobe alveoflex,0,0,0,1,0,1
minnrap peer support program,0,0,1,0,0,1
ml intravenous solution [actemra]_#1,0,0,0,1,0,1
ml intravenous solution [actemra]_#1 (2 doses),0,0,0,1,0,1
ml prefilled syringe [kineret],0,0,0,1,0,1
mls laser,0,1,0,0,0,1
mmrc (modified medical research council) dyspnea scale,0,0,0,1,0,1
mobile internet survey on self-test,0,1,0,0,0,1
model building,0,1,0,0,0,1
model validation,0,1,0,0,0,1
modification,0,0,0,1,0,1
modified rankin score,0,0,0,1,0,1
molgramostim nebuliser solution,0,0,0,1,0,1
mometasone furoate nasal spray,0,1,0,0,0,1
monitoring for aggravation,0,0,0,1,0,1
monitoring visit,0,0,0,1,0,1
monoclonal antibody,0,0,0,1,0,1
montmorrillonite,0,1,0,0,0,1
mortality,0,0,0,1,0,1
mouthrinse with bãªta-cyclodextrin,0,0,0,1,0,1
mouthrinse with bãªta-cyclodextrin/citrox,0,0,0,1,0,1
mouthrinse without bãªta-cyclodextrin,0,0,0,1,0,1
mouthrinse without bãªta-cyclodextrin/citrox,0,0,0,1,0,1
moxibustion,0,0,0,1,0,1
moxibustion/cupping,0,0,0,1,0,1
mr,0,0,0,1,0,1
mr-pro-adm,0,0,0,1,0,1
mr/m-m-r ii â® vaccine,0,0,0,1,0,1
mrna in urine test,1,0,0,0,0,1
mrx-4dp0004,0,0,0,1,0,1
mstt1041a,0,0,0,1,0,1
mucodentol,0,0,0,1,0,1
multicapillary column coupled ion mobility spectrometry,0,0,0,1,0,1
multicomponent treatment virtual fibrowalk,0,0,0,1,0,1
multifrequency bioimpedance spectroscopy,0,0,0,1,0,1
multistem,0,0,0,1,0,1
musclesound ultrasound,0,0,0,1,0,1
n-acetyl cysteine,1,0,0,0,0,1
na-831/atazanavir,0,0,0,1,0,1
na-831/dexamethasone,0,0,0,1,0,1
na (no intervention),0,0,0,1,0,1
nä°cas,0,0,0,1,0,1
nacl solution,0,0,0,1,0,1
naltrexone,0,0,0,1,0,1
nasal high flow,0,1,0,0,0,1
nasal lavage,0,0,1,0,0,1
nasopharyngeal swabs,0,0,0,1,0,1
nasovax,0,0,0,1,0,1
ncapp,0,0,0,1,0,1
negative covid test result - hypothetical scenario,0,1,0,0,0,1
netosis markers,0,0,0,1,0,1
neural network diagnosis algorithm,0,0,0,1,0,1
neuromuscular,0,0,0,1,0,1
neuromuscular electrical stimulation,0,0,0,1,0,1
neutral writing control,1,0,0,0,0,1
newborns,0,1,0,0,0,1
news,0,0,0,1,0,1
newsfeed function,0,0,0,0,1,1
next generation sequencing (ngs) analysis,0,0,0,1,0,1
ng biotech,0,0,0,1,0,1
ng test,0,0,0,1,0,1
nhanes smell,0,0,0,1,0,1
nhanes smell/taste tests,0,0,0,1,0,1
niclosamide suspension,0,0,0,1,0,1
nicotinamide riboside,0,0,0,1,0,1
nigella sativa oil,0,0,0,1,0,1
nil intervention,0,0,0,1,0,1
nioâ® (intraosseous access),1,0,0,0,0,1
nitazoxanide / ivermectin,0,0,0,1,0,1
nitric oxide delivered via lungfitâ„¢ system,0,0,0,1,0,1
nk-1r antagonist,0,0,0,1,0,1
no-immunosuppressive,0,0,0,1,0,1
no instruction regarding positioning,0,0,0,1,0,1
no intervention (survey study for medical doctors).,0,0,0,1,0,1
no intervention / compare the difference in respiratory rate between h0/h12 of the initiation of morphine between the control/interventional groups,0,0,0,1,0,1
no intervention / evaluation of the ferritin/glycosylated ferritin by standard approved serological tests,0,0,0,1,0,1
no intervention on patients,0,0,0,1,0,1
no intervention planned due to the observational study design only a diagnostic testing,0,0,1,0,0,1
"no intervention, observational",0,0,0,1,0,1
no intervention. observational cohort study,0,0,0,1,0,1
no interventional study,0,0,0,1,0,1
no interventions,1,0,0,0,0,1
no interverntion,0,0,0,1,0,1
no special intervention,0,1,0,0,0,1
non,0,0,1,0,0,1
non-acei,1,0,0,0,0,1
non-acei/arb,1,0,0,0,0,1
non-contact mce system,0,1,0,0,0,1
non-enhanced ct scan of the chest,0,1,0,0,0,1
non-hospitalization procedures,0,0,0,1,0,1
non-interventional study,0,0,0,1,0,1
non-invasive red lllt treatment to chest of patient.,0,0,0,1,0,1
non-invasive ventilatory support,1,0,0,0,0,1
non-mindfulness intervention,0,0,0,1,0,1
non intervention,0,0,0,1,0,1
non interventional study,0,0,0,1,0,1
non invasive visual acuity testing,1,0,0,0,0,1
none - na,0,1,0,0,0,1
none - observational,0,0,0,1,0,1
"none, this study is observational",0,0,0,1,0,1
noninvasive ventilation,0,1,0,0,0,1
"normal saline solution (nss), placebo - phase 1",0,0,0,1,0,1
"normal saline solution (nss), placebo - phase 2",0,0,0,1,0,1
"normal saline solution (nss), placebo, day 189 - phase 2",0,0,0,1,0,1
"normal saline solution (nss), placebo, day 21 - phase 1",0,0,0,1,0,1
"normal saline solution (nss), placebo, day 21 - phase 2",0,0,0,1,0,1
"nose swabs, bronchoalveolar lavage ,urine)",0,0,0,1,0,1
nosocomial,0,0,0,1,0,1
not applicable (observational study),0,0,0,1,0,1
not bravery message,0,1,0,0,0,1
np-120 (ifenprodil),0,0,0,1,0,1
nps test,0,0,0,1,0,1
nudge,0,0,0,0,1,1
nusepinâ® 0.1 mg,0,0,0,1,0,1
nusepinâ® 0.2 mg,0,0,0,1,0,1
nutritional assessment,0,0,0,1,0,1
nutritional intervention,0,0,0,1,0,1
nuvastatic,0,0,0,1,0,1
obesity,1,0,0,0,0,1
observation of covid 19 pneumonia,0,0,0,1,0,1
observational cohort study on the natural history of hospitalized sars-cov-2 patients.,1,0,0,0,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal",0,0,0,1,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal/saliva samples",0,0,0,1,0,1
obvio-19 app,0,0,0,1,0,1
odd,0,0,0,1,0,1
odd/even birth year intervention groups,0,0,0,1,0,1
olfactometry,0,0,0,1,0,1
olfactory,0,0,0,1,0,1
olfactory device,0,0,0,1,0,1
olfactory function evaluation,0,0,0,1,0,1
olfactory/gustatory tests,0,0,0,1,0,1
olokizumab,0,1,0,0,0,1
omega 3/nigella sativa oil,0,0,0,1,0,1
omega 3/nigella sativa oil/anise seed capsule,0,0,0,1,0,1
omega 3/nigella sativa oil/deglycyrrhizinated licorice,0,0,0,1,0,1
omega 3/nigella sativa oil/indian costus,0,0,0,1,0,1
omega 3/nigella sativa oil/quinine pills,0,0,0,1,0,1
omeprazole,0,0,0,1,0,1
one covid-19 vaccine candidate (tmv-083) administration - high dose,0,0,0,1,0,1
online intervention mental health covid-19,0,0,0,1,0,1
op-101,0,0,0,1,0,1
ophtamesone,0,0,0,1,0,1
opt-in recruitment email,0,0,1,0,0,1
opt-out recruitment email,0,0,1,0,0,1
optical coherence tomography (oct),0,0,0,1,0,1
optimized management of covid-19 positive kidney transplant recipients: single center experience from the middle east,0,1,0,0,0,1
or ace inhibitors,0,0,0,1,0,1
or antiplatelet) before admission for covid19,0,1,0,0,0,1
"or psychotherapy, n=10)",1,0,0,0,0,1
oral,0,0,0,1,0,1
oral polio vaccine / information,0,0,1,0,0,1
orthopaedic surgical procedures,0,1,0,0,0,1
oseltamivir 75mg,0,0,0,1,0,1
osoc,0,0,0,1,0,1
osteosynthesis,0,1,0,0,0,1
other clinical symptoms,0,1,0,0,0,1
otilimab,0,0,0,1,0,1
oxidative stress elisa kit,0,0,0,1,0,1
oxygen-ozone,0,0,0,1,0,1
oxygen hood,0,1,0,0,0,1
oxyhydrogen,0,0,0,1,0,1
ozanimod,0,0,0,1,0,1
ozone,0,0,0,1,0,1
p2et (caesalpinia spinosa extract),0,0,0,1,0,1
pacritinib,0,0,0,1,0,1
pamrevlumab,0,0,0,1,0,1
pandemic control measures,0,0,0,1,0,1
paracetamol,1,0,0,0,0,1
paraclinical examination,0,0,0,1,0,1
paraclinical test,0,0,0,1,0,1
part 1 - tl-895,0,0,0,1,0,1
part 2 - tl-895,0,0,0,1,0,1
passed infection of sars-cov-2,0,1,0,0,0,1
passive microwave radiometry,0,1,0,0,0,1
patient-centred advice on telephone consultation in tb patients:,0,0,0,1,0,1
patient characteristics,0,1,0,0,0,1
patient sampling,0,0,0,1,0,1
patient with sar-cov-2 infection,0,0,0,1,0,1
patients,1,0,0,0,0,1
patients admitted to intensive care unit with sars-cov2,1,0,0,0,0,1
patients received standard of care treatment during hospitalization,0,0,0,1,0,1
patients with the treatment agains covid19,0,0,0,1,0,1
pb1046,0,0,0,1,0,1
pbmt,0,0,0,1,0,1
pbmt/smf,0,0,0,1,0,1
pcr/chest ct,0,1,0,0,0,1
pct,0,0,0,1,0,1
pct/serology,0,0,1,0,0,1
peep,0,0,0,1,0,1
peer resilience champion,0,0,0,1,0,1
pegylated interferon-î±2b,0,0,0,1,0,1
pembrolizumab,0,0,0,1,0,1
pentoxifylline,1,0,0,0,0,1
percutaneous coronary revascularization for stemi,1,0,0,0,0,1
performance evaluation,0,0,0,1,0,1
performance evaluation study of realdetect rt-pcr kit for covid-19 detection,0,0,0,1,0,1
performing ai algorithms on images,0,0,0,1,0,1
performing of lung ultrasound,0,0,0,1,0,1
personal freedom message,0,1,0,0,0,1
personal protective equipment,0,0,0,1,0,1
personal protective equipment from biological hazard,0,1,0,0,0,1
personal protective testing booth,1,0,0,0,0,1
personalized feedback,0,0,0,1,0,1
personalized health education,0,0,0,1,0,1
pet-ct of 18f-fdg,0,1,0,0,0,1
phase 1,0,0,0,1,0,1
phase 2,0,0,0,1,0,1
phlebotomy,0,0,0,1,0,1
phobia questionairre,0,0,0,1,0,1
phq,0,0,0,1,0,1
phq-9 depression scale,0,0,0,1,0,1
phr160 spray,0,0,0,1,0,1
phsyiotherapy,0,0,0,1,0,1
physiotherapy part of virtual fibrowalk,0,0,0,1,0,1
phytomedicine,0,0,1,0,0,1
pilot a rapid sars-cov-2 testing strategy,0,0,1,0,0,1
pioglitazone,0,0,0,1,0,1
piperacillin,0,0,0,1,0,1
piperacillin/tazobactam,0,0,0,1,0,1
pirfenidone,0,0,0,1,0,1
placebo (0.9% normal saline),0,0,0,1,0,1
placebo (pb0),0,0,0,1,0,1
"placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%)",1,0,0,0,0,1
placebo comparator: dw-ni,0,0,0,1,0,1
placebo comparator: dw-ns,0,0,0,1,0,1
placebo intravenous,0,0,0,1,0,1
placebo mouthwash (water),0,0,1,0,0,1
placebo nebuliser solution,0,0,0,1,0,1
placebo of drug,0,0,1,0,0,1
placebo pmdi,0,0,0,1,0,1
placebo rinse,0,0,0,1,0,1
placebo subcutaneous solution,0,0,0,1,0,1
placebo to match rdv,0,0,0,1,0,1
placebo/aluminum adjuvant of inactivated sars-cov-2 vaccine,0,0,0,1,0,1
placebo/control,0,0,0,1,0,1
placenta-derived mmscs; cryopreserved placenta-derived multipotent mesenchymal stromal cells,0,0,0,1,0,1
plant polyphenol,0,0,0,1,0,1
"platelet count, platelet, mean platelet volume",0,0,0,1,0,1
"platelet count, platelet, mean platelet volume/platelet distribution width in covid-19",0,0,0,1,0,1
platelet distribution width in covid-19,0,0,0,1,0,1
"platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
plethysmography,0,0,0,1,0,1
plethysmography/dlco,0,0,0,1,0,1
plitidepsin,0,0,0,1,0,1
plx-pad,0,0,0,1,0,1
point-of-care test for sars-cov-2,0,0,0,1,0,1
polio vaccine,0,0,1,0,0,1
polyoxidonium,1,0,0,0,0,1
polysomnography,1,0,0,0,0,1
poractant alfa,0,0,0,1,0,1
position,0,0,0,1,0,1
positive covid test result - hypothetical scenario,0,1,0,0,0,1
positive feedback,0,1,0,0,0,1
post-traumatic stress screening,0,0,0,1,0,1
post covid-19 functional satus scale,0,0,0,1,0,1
postpartum,0,0,0,1,0,1
postpartum women under investigation for coronavirus/diagnosed with covid-19,0,0,0,1,0,1
postural positioning,0,0,0,1,0,1
povidone,0,0,0,1,0,1
prayer,0,0,0,1,0,1
prazosin,0,0,0,1,0,1
pre-operative screening,0,0,0,1,0,1
predict admission of covid-19 patients to icu,1,0,0,0,0,1
"predict admission of covid-19 patients to icu/death with routine/quickly avalaible clinical, biological/radiological variables?",1,0,0,0,0,1
prediction market,0,1,0,0,0,1
predictive factors for clinical response in patients with covid-19.,0,0,0,1,0,1
predictors adverse evolution,0,0,0,1,0,1
predictors of health care provide,0,0,0,1,0,1
pregnant women under investigation for coronavirus,0,0,0,1,0,1
pregnant women under investigation for coronavirus/diagnosed with covid-19,0,0,0,1,0,1
preservision areds formulation gel tabs,0,0,1,0,0,1
prevalence of covid-19,0,1,0,0,0,1
primary care,0,1,0,0,0,1
"primary care professionals reports of potential patient safety incidents, non-covid-19 related",0,0,0,1,0,1
primepro,0,1,0,0,0,1
"pro bnp , vitamin d",0,0,0,1,0,1
probiorinse,0,0,0,1,0,1
probiotics,0,0,0,1,0,1
problem-solving,0,0,0,1,0,1
problem-solving/relationship improvement intervention.,0,0,0,1,0,1
procalcitonin,0,0,0,1,0,1
progesterone,1,0,0,0,0,1
prognostic score,1,0,0,0,0,1
progressive cycling exercise test to exhaustion,0,0,0,1,0,1
prolastin,0,0,0,1,0,1
prolectin-m; a (1-6)-alpha-d-mannopyranose class,0,0,0,1,0,1
prophylactic,0,0,0,1,0,1
prophylaxis,0,1,0,0,0,1
propofol,0,0,0,1,0,1
prospective chart review,0,0,1,0,0,1
prospective oberservational registry,0,0,0,1,0,1
prototype,0,0,0,1,0,1
proxalutamide,0,0,0,1,0,1
psg,0,0,0,1,0,1
psqi,0,1,0,0,0,1
pss,0,0,0,1,0,1
psychoeducation,0,0,0,1,0,1
psychoeducational intervention,0,0,0,1,0,1
psychological stress,0,1,0,0,0,1
psychological stress/adaptation at work score (psas),0,1,0,0,0,1
psychological/behaviour change support,0,0,0,1,0,1
psychological/sociological interviews,1,0,0,0,0,1
ptc299,0,0,0,1,0,1
public health england gold standard,0,0,0,1,0,1
pulmonary anomalies 4 months after documented covid-19 pneumonia,0,0,0,1,0,1
pulmonary function testing,0,0,0,1,0,1
pulmonary function tests,0,0,0,1,0,1
pulmonary physiotherapy techniques,0,1,0,0,0,1
pulmonary rehabilitation,0,1,0,0,0,1
pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),0,0,0,1,0,1
pulse oximetry,0,0,0,1,0,1
pwv,0,0,0,1,0,1
pyridostigmine bromide,0,0,0,1,0,1
q-nrg metobolic cart device,0,0,0,1,0,1
q spect-ct,0,0,0,1,0,1
qazcovid-inâ® - covid-19 inactivated vaccine,0,0,1,0,0,1
quadramune(tm),0,0,0,1,0,1
qualitative assessments of mental health,0,0,0,1,0,1
quality of life promotion,0,0,1,0,0,1
quality of life questionnaires,0,0,0,1,0,1
quality of live assessment,0,0,0,1,0,1
quantitative,0,0,0,1,0,1
quantitative analysis of anti-sars-cov-2-antibodies,0,1,0,0,0,1
quantitative analysis of sars-cov-2 antibodies,0,1,0,0,0,1
quantitative igg test,1,0,0,0,0,1
quantitative/qualitative assessments of mental health,0,0,0,1,0,1
quantra system,0,0,1,0,0,1
questionaire,0,1,0,0,0,1
"quickly avalaible clinical, biological",1,0,0,0,0,1
quinine,0,0,0,1,0,1
quinquina-stevia,0,0,1,0,0,1
quinquina-stevia/azythromycin,0,0,1,0,0,1
r tablets,1,0,0,0,0,1
radiological variables?,1,0,0,0,0,1
ramipril,0,0,1,0,0,1
rapid-3,0,0,0,1,0,1
rapid molecular test,0,0,0,1,0,1
rapid salivary test,0,0,0,1,0,1
rapid serological test,0,0,0,1,0,1
rarefaction,0,0,0,1,0,1
razuprotafib,0,0,0,1,0,1
razuprotafib subcutaneous solution,0,0,0,1,0,1
rbt-9 (90 mg),0,0,0,1,0,1
rdv,0,0,0,1,0,1
reactivity,0,0,0,1,0,1
reading a book,0,0,0,1,0,1
recharge,0,0,0,1,0,1
recombinant human interferon î±2b spray,1,0,0,0,0,1
recombinant human plasma gelsolin (rhu-pgsn),0,0,0,1,0,1
recombinase,0,0,0,1,0,1
rectal swab,0,0,0,1,0,1
referral card,0,0,0,1,0,1
reginmune,0,0,0,1,0,1
registery data collection,0,0,0,1,0,1
regular care,0,0,0,1,0,1
rehabilitation,0,1,0,0,0,1
relation between frailty,0,0,0,1,0,1
relation between frailty/clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
relationship improvement intervention.,0,0,0,1,0,1
remain covid free ssi,0,0,0,1,0,1
remestemcel-l,0,0,0,1,0,1
remote cognitive behavioral therapy for insomnia,0,0,0,1,0,1
remote pulmonary rehabilitation,0,0,0,1,0,1
removal of dead space filter,0,0,0,1,0,1
renin-angiotensin system inhibitors,0,0,0,1,0,1
"reporting of anosmia, ageusia",0,1,0,0,0,1
"reporting of anosmia, ageusia/other clinical symptoms",0,1,0,0,0,1
research specific blood sample,0,0,0,1,0,1
"resp301, a nitric oxide generating solution",0,0,0,1,0,1
respiratory function rehabilitation training,0,0,0,1,0,1
respiratory mechanics measurement,0,1,0,0,0,1
respiratory monitor,0,0,0,1,0,1
respiratory physiotherapy,0,0,0,1,0,1
respiratory rehabilitation,0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety",0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety/depression,/post-traumatic stress screening",0,0,0,1,0,1
respiratory tract sample,0,0,0,1,0,1
retrospective,0,0,0,1,0,1
retrospective case-control analysis,0,1,0,0,0,1
retrospective metagenomics on clinical samples collected during hospitalization,1,0,0,0,0,1
reverse transcription polymerase chain reaction,0,1,0,0,0,1
rh-dnase,0,0,0,1,0,1
rhace2,0,0,0,1,0,1
rhinopharyngeal,0,1,0,0,0,1
rhtpo,0,0,0,1,0,1
ria-device (remote investigation,0,0,0,1,0,1
ria-device (remote investigation/assessment),0,0,0,1,0,1
right lateral decubitus),0,0,0,1,0,1
rintatolimod,0,0,0,1,0,1
risk factors,0,1,0,0,0,1
ritonavir placebo,0,0,0,1,0,1
ritonavir/oseltamivir,0,0,0,1,0,1
roactemra,0,0,0,1,0,1
robot assisted percutaneous cardiovascular intervention,0,0,0,1,0,1
rosuvastatin,0,0,0,1,0,1
rph-104,0,1,0,0,0,1
rtb101,0,0,0,1,0,1
sab-185,0,0,0,1,0,1
saline-sodium citrate (ssc) buffer,0,0,0,1,0,1
saline containing 1% human serum albuminï¼ˆsolution without uc-mscsï¼‰,0,1,0,0,0,1
saline with baby shampoo nasal irrigation,0,0,0,1,0,1
saline/standard care,0,0,0,1,0,1
saliva/nps test,0,0,0,1,0,1
salivary,0,1,0,0,0,1
samba ii,0,0,0,1,0,1
sample collection/performance evaluation (a),0,0,0,1,0,1
sample collection/performance evaluation (b),0,0,0,1,0,1
sar443122,0,0,0,1,0,1
sars-cov-2-test,0,0,0,1,0,1
sars-cov-2 ab,0,1,0,0,0,1
sars-cov-2 antibody based ivig therapy,0,0,0,1,0,1
sars-cov-2 antibody immunoassays,1,0,0,0,0,1
sars-cov-2 antibody testing,0,0,0,1,0,1
sars-cov-2 infection,1,0,0,0,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm",0,0,0,1,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm/serologics",0,0,0,1,0,1
sars-cov-2 s1,0,0,0,1,0,1
sars-cov-2 s1/s2 igg,0,0,0,1,0,1
sars-cov-2 specific t cells,0,0,0,1,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 1,0,0,0,1,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 2,0,0,0,1,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 1,0,0,0,1,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 2,0,0,0,1,0,1
sars-cov-2 vaccine formulation 2 without adjuvant,0,0,0,1,0,1
sars-cov2 infection,0,0,0,1,0,1
sars-cov2 testing,0,0,0,1,0,1
satisfaction evaluation,0,0,0,1,0,1
savr,1,0,0,0,0,1
scanning chest x-rays/performing ai algorithms on images,0,0,0,1,0,1
scb-2019,0,0,0,1,0,1
scb-2019 with as03 adjuvant,0,0,0,1,0,1
scb-2019 with cpg 1018 adjuvant,0,0,0,1,0,1
scb-2019 with cpg 1018 adjuvant/alum adjuvant,0,0,0,1,0,1
scd,0,0,0,1,0,1
sch intervention,0,0,1,0,0,1
sedation,0,0,0,1,0,1
self-administered questionnaire,0,1,0,0,0,1
self-compassion for chronic pain virtual group treatment program,0,0,0,1,0,1
self-help booklet,1,0,0,0,0,1
self-interest message,0,1,0,0,0,1
self-management booklet (switch: stay well during covid-19),1,0,0,0,0,1
self-questionnary,0,0,0,1,0,1
self study,0,0,0,1,0,1
selinexor,0,0,0,1,0,1
semen qualitative analysis,0,0,0,1,0,1
semi-directive interview,0,0,0,1,0,1
sequencing,0,0,0,1,0,1
seraph,0,0,0,1,0,1
seraphâ®-100 microbindâ® affinity blood filter,0,0,0,1,0,1
serial seroconversion measurements in hospital employees during the covid-19 pandemic,0,0,0,1,0,1
serologic assays for antibodies to sars-cov-2,0,0,0,1,0,1
serologic immunoassays to sars-cov-2 antibodies,0,0,0,1,0,1
seroprevalence of sars-cov-2 infection in patients with hiv infection,0,0,0,1,0,1
serum,0,0,0,1,0,1
serum neurofilaments as a marker of neurological damage.,0,0,0,1,0,1
serum neutralization,0,0,0,1,0,1
sessions,1,0,0,0,0,1
shared decision making,0,0,1,0,0,1
shg,0,0,0,1,0,1
sildenafil,0,0,0,1,0,1
sildenafil citrate,0,0,0,1,0,1
silymarin,0,0,0,1,0,1
simha kriya,0,0,0,1,0,1
simple cognitive task intervention,0,0,0,1,0,1
simulation of repurposed drugs for covid-19,1,0,0,0,0,1
simvastatin,0,0,0,1,0,1
sirukumab,0,0,0,1,0,1
six-minute walk test (6mwt),0,0,0,1,0,1
sledd with a l-mod,0,0,0,1,0,1
smf,0,0,0,1,0,1
sms-based support,0,0,0,1,0,1
sms message support,1,0,0,0,0,1
sng001,0,0,0,1,0,1
soc / ifx-1,0,0,0,1,0,1
soc / intravenous famotidine,0,0,0,1,0,1
social distancing,0,1,0,0,0,1
social media,0,0,0,1,0,1
social media/news consumption,0,0,0,1,0,1
sodium bicarbonate,1,0,0,0,0,1
sofosbuvir/daclatasvir,0,0,0,1,0,1
sonclot coagulation,0,1,0,0,0,1
"sonclot coagulation/platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
SOP,0,0,0,1,0,1
sorbitol,0,0,0,1,0,1
spartan covid-19 system,0,0,0,1,0,1
specific anti-sars-cov-2 antibodies,0,0,0,1,0,1
specific exercise rehabilitation treatment,0,0,0,1,0,1
specimen collection,0,0,0,1,0,1
speq (specific psychotic experiences questionnaire) - paranoia,0,0,0,1,0,1
speq (specific psychotic experiences questionnaire) - paranoia/grandiosity subscales,0,0,0,1,0,1
spin-chat program,0,1,0,0,0,1
spirometry,0,0,0,1,0,1
st. george's respiratory questionnaire (sgrq),0,0,0,1,0,1
staff wellbeing centres,0,0,0,1,0,1
standard-titer convalescent covid-19 plasma (ccp2),0,0,0,1,0,1
standard interface,0,1,0,0,0,1
standard of care (paracetamol),0,0,0,1,0,1
standard of care (soc)/placebo,0,0,0,1,0,1
standard of care thromboprophylaxis,0,0,0,1,0,1
standard prophylactic dose enoxaparin,0,0,0,1,0,1
standard prophylactic dose enoxaparin/ unfractionated heparin,0,0,0,1,0,1
standard treatment for covid-19,0,0,0,1,0,1
statins,1,0,0,0,0,1
stc-19,0,1,0,0,0,1
stellate ganglion block,0,0,0,1,0,1
stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,0,0,0,1,0,1
stress,0,0,0,1,0,1
stress scale,0,0,0,1,0,1
stress/anxiety questionnaire,0,0,0,1,0,1
study a,0,0,0,1,0,1
study arm,0,0,0,1,0,1
study b,0,0,0,1,0,1
study c,0,0,0,1,0,1
study d,0,0,0,1,0,1
study of immune-mediated mechanisms in patients tested positive for sars-cov-2,0,0,0,1,0,1
sudarshan kriya yoga (sky),0,0,0,1,0,1
sulfamethoxazole,0,0,0,1,0,1
sulodexide,0,1,0,0,0,1
supine positioning,0,0,0,1,0,1
supportive/symptomatic treatment,1,0,0,0,0,1
surfactant,0,0,0,1,0,1
surge capacity,0,1,0,0,0,1
surgery,0,0,0,1,0,1
"surgery: dynamic hip screw, hemiarthroplasty, hip replacement, intramedullary nail",0,1,0,0,0,1
surgical facial mask,0,1,0,0,0,1
surgical procedures performed under general anesthesia,0,1,0,0,0,1
survey/questionnaire,1,0,0,0,0,1
surveys/questionnaires,0,1,0,0,0,1
susceptibility to infection,0,0,0,1,0,1
suspension,0,0,0,1,0,1
suspension of heat killed (autoclaved) mycobacterium w,0,0,0,1,0,1
suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors,0,0,0,1,0,1
swab,0,0,0,1,0,1
swallowing evaluation with the eat-10,0,0,0,1,0,1
swallowing evaluation with the eat-10/the volume-viscosity swallowing test (v-vst),0,0,0,1,0,1
sweat samples (covidog ancillary study),0,0,0,1,0,1
symbicort,0,0,0,1,0,1
symptom,1,0,0,0,0,1
symptom/exposure surveys,1,0,0,0,0,1
symptomatic treatment,1,0,0,0,0,1
symptomatic treatment (paracetamol,0,0,0,1,0,1
symptomatic treatment (paracetamol),0,0,0,1,0,1
symptomatic treatment (paracetamol/best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
"symptomatology, treatment. daily activities",0,0,0,1,0,1
synthetic neutralising antibodies,0,0,0,1,0,1
systemic,0,0,0,1,0,1
t cell derived exosom,1,0,0,0,0,1
t3 solution,0,0,0,1,0,1
tacrolimus,0,0,0,1,0,1
taking biological samples,0,0,0,1,0,1
tape-software,0,0,0,1,0,1
taste/olfactory function evaluation,0,0,0,1,0,1
tau,0,0,0,1,0,1
tau / multicomponent treatment virtual fibrowalk,0,0,0,1,0,1
tau / physiotherapy part of virtual fibrowalk,0,0,0,1,0,1
tavr,1,0,0,0,0,1
tavr/savr,1,0,0,0,0,1
tazobactam,0,0,0,1,0,1
tcc-covid mhealth,0,0,0,1,0,1
tcm,0,1,0,0,0,1
td139,0,0,0,1,0,1
tears swab,0,1,0,0,0,1
tele-interventions related to diabetes management,0,0,1,0,0,1
tele-interventions related to diabetes management/mental well-being,0,0,1,0,0,1
telemedicine to remote outpatient visit in bariatric patient,0,1,0,0,0,1
telephone consult,0,0,0,1,0,1
telephone follow-up,0,0,0,1,0,1
telephone interview,1,0,0,0,0,1
telesimulation,0,0,0,1,0,1
tem-tpa,0,0,0,1,0,1
tenecteplase,0,0,0,1,0,1
tenofovir,0,0,0,1,0,1
tenofovir disoproxil,0,0,0,1,0,1
tested for sars-cov-2 (regardless of the result),0,0,0,1,0,1
testing for sars-cov-2,1,0,0,0,0,1
testing sensitivity for sars-cov-2 virus in symptomatic individuals,0,1,0,0,0,1
tetrandrine,0,0,1,0,0,1
"the demographic, clinical, laboratory,",0,0,0,1,0,1
"the demographic, clinical, laboratory,/instrumental data",0,0,0,1,0,1
the management of severe covid-19 cases,0,0,0,1,0,1
the placenta,0,0,0,1,0,1
therapeutic exercise,0,0,1,0,0,1
therapeutic exercise/education,0,0,1,0,0,1
theraputic heparin,0,0,0,1,0,1
therapy intervention,0,0,0,1,0,1
there is no intervention in this study,0,0,0,1,0,1
thoracic ct,0,0,0,1,0,1
thoracic ct-scan,0,0,0,1,0,1
thoracic lung ultrasound,0,0,0,1,0,1
thoraxic computed tomography,0,0,0,1,0,1
throat swab sample for measuring current infection with sars-cov-2,0,0,0,1,0,1
thrombin,0,0,0,1,0,1
thromboprofylaxis protocol,0,1,0,0,0,1
thymalfasin,0,0,0,1,0,1
thymosin,0,0,0,1,0,1
tigeraseâ®,0,0,0,1,0,1
tigeraseâ®/best available care,0,0,0,1,0,1
tinzaparin,0,1,0,0,0,1
tinzaparin/dalteparin,0,1,0,0,0,1
tirofiban,0,1,0,0,0,1
titanium blood test,0,0,0,1,0,1
tj003234,0,0,0,1,0,1
tlrs activation measurement,0,0,0,1,0,1
tnkase,1,0,0,0,0,1
tociliuzumab,0,1,0,0,0,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1,0,0,0,1,0,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),0,0,0,1,0,1
tof protocol,0,1,0,0,0,1
tomography angiography,0,1,0,0,0,1
tracheostomy,0,0,0,1,0,1
tracheostomy with aerosol box in covid-19 positive patients,0,1,0,0,0,1
tracheotomy,0,0,0,1,0,1
tradipitant,0,0,1,0,0,1
training clinicians in basic critical care,0,0,0,1,0,1
training clinicians in basic critical care/the management of severe covid-19 cases,0,0,0,1,0,1
"training for awareness, resilience,",0,1,0,0,0,1
"training for awareness, resilience,/action (tara)",0,1,0,0,0,1
"training of youth, community health assistants",0,0,0,1,0,1
"training of youth, community health assistants/community health workers.",0,0,0,1,0,1
training session adressing information,0,0,0,1,0,1
training session adressing information/health literacy,0,0,0,1,0,1
tranexamic acid,0,0,0,1,0,1
trans sodium crocetinate,0,0,0,1,0,1
transcutaneous auricular vagus nerve stimulation,0,0,0,1,0,1
transplant patient,1,0,0,0,0,1
transpulmonary pressure measurements,0,0,0,1,0,1
transpulmonary thermodilution,0,0,0,1,0,1
trauma-informed yoga video recording,0,0,0,1,0,1
treamid,0,0,0,1,0,1
treatment,0,1,0,0,0,1
treatment as usual (tau),0,0,0,1,0,1
treatment for covid-19,0,0,0,1,0,1
treatment/prophylaxis,0,1,0,0,0,1
tridecactide,1,0,0,0,0,1
trimethoprim,0,0,0,1,0,1
trimethoprim/sulfamethoxazole,0,0,0,1,0,1
trimoxazole,0,0,0,1,0,1
trust in science message,0,1,0,0,0,1
tsvf,0,0,1,0,0,1
tuberculin,0,0,0,1,0,1
turkish physicians,0,1,0,0,0,1
two covid-19 vaccine candidate (tmv-083) administrations - high dose,0,0,0,1,0,1
two covid-19 vaccine candidate (tmv-083) administrations - low dose,0,0,0,1,0,1
"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,0,0,1
"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,0,0,1
"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,0,0,1
txa127,0,0,0,1,0,1
ultra brief online mindfulness-based intervention,0,1,0,0,0,1
umbilical cord mesenchymal stem cells / heparin along with best supportive care.,1,0,0,0,0,1
umifenovir,0,0,1,0,0,1
unavailable covid test result - hypothetical scenario,0,1,0,0,0,1
unfractionated heparin iv,0,0,0,1,0,1
unfractionated heparin sc,0,0,0,1,0,1
unified protocol for covid-19 parenting stress (up-covid),0,0,0,1,0,1
unsupervised physical activities,0,0,0,1,0,1
"urinary ngal, timp-2, igfbp7, il-6, viral load",0,0,0,1,0,1
"urinary ngal, timp-2, igfbp7, il-6, viral load/metabolomic",0,0,0,1,0,1
usual antibiotic treatment,0,0,0,1,0,1
usual care positioning with no instructions,1,0,0,0,0,1
usual practice / symbicort rapihaler,0,0,0,1,0,1
utooth btc),0,0,0,1,0,1
uttr1147a,0,0,0,1,0,1
uv light treatment,0,0,0,1,0,1
v,0,0,0,1,0,1
v-sars,1,0,0,0,0,1
v/q spect-ct,0,0,0,1,0,1
v591,0,0,0,1,0,1
vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,0,0,0,1,0,1
vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,0,0,0,1,0,1
vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,0,0,0,1,0,1
vadadustat,0,0,0,1,0,1
vehicle,1,0,0,0,0,1
vehicle / heparin along with best supportive care,1,0,0,0,0,1
vehicle control,0,0,0,1,0,1
venipuncture in peripheral vein,0,0,0,1,0,1
verapamil,0,0,0,1,0,1
veru-111,0,0,0,1,0,1
vib7734,0,0,0,1,0,1
vibrolung,0,0,0,1,0,1
video chat,0,0,0,1,0,1
video chat / basic feedback,0,0,0,1,0,1
video chat /personalized feedback,0,0,0,1,0,1
video dance classes,0,0,0,1,0,1
vielight rx plus,0,0,0,1,0,1
views,0,0,0,1,0,1
vir-7831,0,0,0,1,0,1
virtual care at home,0,0,0,1,0,1
virtual group intervention,0,0,0,1,0,1
virtual reality,0,0,0,1,0,1
virtual reality therapy first,1,0,0,0,0,1
viruxal oral,0,0,0,1,0,1
viruxal oral/nasal spray,0,0,0,1,0,1
visual prompts,0,1,0,0,0,1
vitamin b,0,0,0,1,0,1
vitamin c tablets,0,0,0,1,0,1
vitamin e,1,0,0,0,0,1
vitamins,0,0,0,1,0,1
viusid,0,0,0,1,0,1
viusid/asbrip,0,0,0,1,0,1
volatile organic compounds analysis,0,0,0,1,0,1
volume rapid test,0,0,0,1,0,1
vv-ecmo / cytokine adsorption,0,0,0,1,0,1
vxa-cov2-1,0,0,0,1,0,1
water without an elevated level of kelea,0,0,0,1,0,1
wearing surgical face mask sprayed with hypertonic saline,0,0,0,1,0,1
web-based redcap survey,0,0,0,1,0,1
web application users,0,0,0,1,0,1
weekly assessment,0,0,0,1,0,1
who recommendations (waiting condition),0,0,0,1,0,1
whoqol-bref,0,0,0,1,0,1
withings scanwatch,0,0,0,1,0,1
woebot substance use disorder,0,0,0,1,0,1
x-ray,0,0,0,1,0,1
xav-19,0,0,0,1,0,1
xc221,0,0,0,1,0,1
xcel-umc-beta,0,0,0,1,0,1
yoga group,1,0,0,0,0,1
zanubrutinib,0,0,0,1,0,1
zaritt burden interview,0,0,0,1,0,1
zavegepant (bhv-3500),0,0,0,1,0,1
zidovudine,0,1,0,0,0,1
zilucoplanâ®,0,0,0,1,0,1
zinc citrate,0,0,0,1,0,1
zithromax,0,0,0,1,0,1
zofin,0,0,0,1,0,1
